- The Washington Times - Monday, July 15, 2013

A clinical trial has found two treatment options to cure increasingly drug-resistant modern strains of gonorrhea, but they often have side effects, and federal officials called for more research Monday.

Gonorrhea patients now must get a shot and round of oral antibiotics to kill the sexually transmitted disease, which has developed new defenses against modern drugs.

A clinical trial with 401 gonorrhea patients now has shown that two more anti-gonorrhea regimens — one with a shot and oral antibiotics, and the other with two oral antibiotics — were 100 percent or 99.5 percent effective.

Unfortunately, both regimens had adverse side effects. Roughly a third of the patients experienced nausea, and about a fifth experienced diarrhea.

“Patients need more oral options with fewer side effects,” said Dr. Gail Bolan, director of the Division of STD Prevention at the Centers for Disease Control and Prevention.

Gonorrhea is a common disease, with an estimated 800,000 new infections every year in the United States. The sexually transmitted disease has been curable since the 1930s, but it persistently has become drug-resistant and is curable today with an injection of ceftriaxone combined with oral azithromycin or oral doxycycline.

The clinical trial treatments — which will be reported this week at an international STD conference in Austria — studied oral azithromycin combined with either a shot of gentamicin or a round of oral gemifloxicin.

Untreated gonorrhea is associated with painful urination, pelvic pain, ectopic pregnancy and infertility.

Copyright © 2018 The Washington Times, LLC. Click here for reprint permission.

The Washington Times Comment Policy

The Washington Times is switching its third-party commenting system from Disqus to Spot.IM. You will need to either create an account with Spot.im or if you wish to use your Disqus account look under the Conversation for the link "Have a Disqus Account?". Please read our Comment Policy before commenting.


Click to Read More and View Comments

Click to Hide